Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
AstraZeneca
Cipla
Merck
Cerilliant
Accenture
Dow
QuintilesIMS

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020961

« Back to Dashboard

NDA 020961 describes VITRAVENE PRESERVATIVE FREE, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the VITRAVENE PRESERVATIVE FREE profile page.

The generic ingredient in VITRAVENE PRESERVATIVE FREE is fomivirsen sodium. Additional details are available on the fomivirsen sodium profile page.
Summary for 020961
Tradename:VITRAVENE PRESERVATIVE FREE
Applicant:Novartis
Ingredient:fomivirsen sodium
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength6.6MG/ML
Approval Date:Aug 26, 1998TE:RLD:No

Expired US Patents for NDA 020961

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis VITRAVENE PRESERVATIVE FREE fomivirsen sodium INJECTABLE;INJECTION 020961-001 Aug 26, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Cerilliant
Fuji
Queensland Health
Cipla
US Department of Justice
McKesson
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.